Potency of cell-mediated immune responses to different combined HIV-1 immunogens in a humanized murine model.

Human vaccines

Volumn 1, Issue 4, 2005, Pages 170-176

  Azizi, Ali ^a   Ghorbani, Masoud ^a   Kryworuchko, Marko ^a   Aucoin, Susan ^a   Diaz Mitoma, Francisco ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAG PROTEIN; GLYCOPROTEIN GP 120; HLA A2 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; PEPTIDE; POL PROTEIN; RECOMBINANT VACCINE; VIRUS DNA;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHO CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOLOGY; METABOLISM; MOUSE; PLASMID; TRANSGENIC MOUSE; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; CHO CELLS; CRICETINAE; CYTOKINES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE PRODUCTS, POL; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP120; HIV-1; HLA-A2 ANTIGEN; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION SCHEDULE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; PEPTIDES; PLASMIDS; TRANSFECTION; VACCINES, SYNTHETIC;

EID: 33750579820     PISSN: 15548600     EISSN: None     Source Type: Journal    
DOI: 10.4161/hv.1.4.1990     Document Type: Article

References (0)